GKCC

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 25, 2023	Elicio Therapeutics	$7.0M Other Equity	GKCC	—
Oct 1, 2023	Actym Therapeutics, Inc.	$26.0M Series A	Illumina Ventures, Boehringer Ingelheim	Boehringer Ingelheim Venture Fund, JLo Ventures

Total Raised

N/A

Valuation

N/A